Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Modulation of Kaposi's sarcoma-associated herpesvirus interleukin-6 function by hypoxia-upregulated protein 1.
[primary effusion lymphoma]
Kaposi
's
sarcoma
-associated
herpesvirus
(
KSHV
,
also
called
human
herpesvirus
8
)
is
linked
to
the
development
of
Kaposi
's
sarcoma
(
KS
)
,
primary
effusion
lymphoma
(
PEL
)
,
and
multicentric
Castleman
's
disease
(
MCD
)
.
KSHV
expresses
several
proteins
that
modulate
host
cell
signaling
pathways
.
One
of
these
proteins
is
viral
interleukin-
6
(
vIL-
6
)
,
which
is
a
homolog
of
human
IL
-
6
(
hIL-
6
)
.
vIL-
6
is
able
to
prevent
apoptosis
and
promote
proinflammatory
signaling
,
angiogenesis
,
and
cell
proliferation
.
Although
it
can
be
secreted
,
vIL-
6
is
mainly
an
intracellular
protein
that
is
retained
in
the
endoplasmic
reticulum
(
ER
)
.
We
performed
affinity
purification
and
mass
spectrometry
to
identify
novel
vIL-
6
binding
partners
and
found
that
a
cellular
ER
chaperone
,
hypoxia-upregulated
protein
1
(
HYOU
1
)
,
interacts
with
vIL-
6
.
Immunohistochemical
staining
reveals
that
both
PEL
and
KS
tumor
tissues
express
significant
amounts
of
HYOU
1
.
We
also
show
that
HYOU
1
increases
endogenous
vIL-
6
protein
levels
and
that
HYOU
1
facilitates
vIL-
6
-
induced
JAK
/
STAT
signaling
,
migration
,
and
survival
in
endothelial
cells
.
Furthermore
,
our
data
suggest
that
HYOU
1
also
modulates
vIL-
6
's
ability
to
induce
CCL
2
,
a
chemokine
involved
in
cell
migration
.
Finally
,
we
investigated
the
impact
of
HYOU
1
on
cellular
hIL-
6
signaling
.
Collectively
,
our
data
indicate
that
HYOU
1
is
important
for
vIL-
6
function
and
may
play
a
role
in
the
pathogenesis
of
KSHV-associated
cancers
.
KSHV
vIL-
6
is
detectable
in
all
KSHV-associated
malignancies
and
promotes
tumorigenesis
and
inflammation
.
We
identified
a
cellular
protein
,
called
hypoxia-upregulated
protein
1
(
HYOU
1
)
,
that
interacts
with
KSHV
vIL-
6
and
is
present
in
KSHV-infected
tumors
.
Our
data
suggest
that
HYOU
1
facilitates
the
vIL-
6
-
induced
signaling
,
migration
,
and
survival
of
endothelial
cells
.
Diseases
Validation
Diseases presenting
"lymphoma"
symptom
adrenal incidentaloma
alpha-thalassemia
carcinoma of the gallbladder
cushing syndrome
dedifferentiated liposarcoma
erdheim-chester disease
erythropoietic protoporphyria
esophageal adenocarcinoma
esophageal carcinoma
familial hypocalciuric hypercalcemia
focal myositis
hirschsprung disease
hodgkin lymphoma, classical
kabuki syndrome
liposarcoma
locked-in syndrome
monosomy 21
oculocutaneous albinism
primary effusion lymphoma
severe combined immunodeficiency
systemic capillary leak syndrome
waldenström macroglobulinemia
wiskott-aldrich syndrome
This symptom has already been validated